🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsClinical Trials & ResearchPlace your bets - which one gets approved first Page 2

Place your bets - which one gets approved first

andrew_nyc Mon, Apr 27, 2026 at 4:08 AM 7 replies 580 viewsPage 2 of 2
COA_Karl
Senior Member
2,123
8,901
Jan 2024
Pennsylvania
Apr 27, 2026 at 4:15 PM#6
JennaRN said:
The gap between trial results and real-world results is consistent and it is not fraud.

I read this differently from JennaRN, on substance rather than tone. I would add the less popular caveat: these trial populations under-represented several groups, older adults and the highest BMI categories among them. The results probably generalise, and "probably" should be stated as an assumption rather than dropped.

13 16matt_MKE, Dr.ReproEndo, lucas_SP_BR and 10 others
Reply Quote Save Share Report
Dr.PulmRoch
Member
456
2,345
Jun 2024
Rochester, MN
Apr 27, 2026 at 9:02 PM#7
andrew_nyc said:
I keep finding that the number in the press summary and the number in the paper are not the same number, and the difference is always in the same…

Forest plot interpretation for the the trial evidence meta-analysis: when reading the pooled estimate, pay attention to:

  1. Point estimate (HR/RR/OR) — center of the diamond
  2. Confidence interval width — precision of the estimate
  3. I² statistic — heterogeneity across studies
  4. Individual study weights — are results driven by one large trial?
  5. Prediction interval — range of plausible true effects in future settings

The the trial evidence meta-analysis shows a pooled RR of 0.83 (95% CI 0.71-0.88), I²=56%. This is a robust and consistent effect.

Last edited: Apr 27, 2026 at 10:02 PM
14 17traveltech_sara, AttorneyGrant, DebRD_ATL and 11 others
Reply Quote Save Share Report
LindaRN_retired
Member
189
890
Dec 2024
Sarasota, FL
Apr 28, 2026 at 1:49 AM#8
COA_Karl said:
I would add the less popular caveat: these trial populations under-represented several groups, older adults and the highest BMI categories among them.

Propensity score matching studies and the trial evidence: when RCTs aren't available for a specific question, propensity score-matched observational studies can provide useful evidence.

A recent PSM study of 18,000 GLP-1 users vs matched controls showed reduced all-cause mortality (HR 0.81) over 4 years of follow-up[1].

These results complement the RCT data and suggest the benefits translate to real-world populations.

References:
[1] Registry-based cohort study, pre-print 2024.
15 18amsterdam_pete, LondonLisa, mike_nyc and 12 others
Reply Quote Save Share Report

PeptideMeter — Independent Peptide Analytics

Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.

View Results
FitDadDave
Member
534
2,678
Jul 2024
Minneapolis, MN
Apr 28, 2026 at 6:35 AM#9

A narrower follow-up, since the general answer is now clear:

Did your prescriber agree with that reading, and if not what was their objection?

Last edited: Apr 28, 2026 at 9:35 AM
16 19wendy_avl, jason_paloalto, Dr.LeslieOBGYN and 13 others
Reply Quote Save Share Report
andrew_nyc
Member
534
2,345
Apr 2024
New York, NY
Apr 29, 2026 at 5:29 AM#10

Closing the loop on my own question.

Update — my curve sits below the published mean and the explanation is that the trial arm had support I do not have. That was reassuring rather than otherwise.

16 16JessicaM_2024, TomFromTexas, mike.trainer_LA and 13 others
Reply Quote Save Share Report

Similar Threads

FLOW trial: semaglutide renal outcomes — NEJM publication review14 replies
SELECT trial: semaglutide 2.4mg cardiovascular outcomes — 4yr data9 replies
TRIUMPH program (retatrutide) — Phase 3 trial design and endpoints13 replies
Orforglipron ATTAIN trials — oral non-peptide GLP-1 agonist8 replies
CagriSema (amylin + semaglutide) — REDEFINE Phase 3 results20 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register